HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IG Inquiry Clears Crawford Of Three Personal Conduct Allegations

This article was originally published in The Rose Sheet

Executive Summary

The conclusion of the HHS Inspector General's investigation into allegations against FDA Commissioner-nominee Lester Crawford could remove one roadblock in his confirmation process
Advertisement

Related Content

Crawford closer to confirmation
Crawford closer to confirmation
FDA Confirmation Process Hits A Roadblock: Time For Plan B?
FDA Confirmation Process Hits A Roadblock: Time For Plan B?
Advertisement
UsernamePublicRestriction

Register

RS013113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel